Forbes August 10, 2022
Konstanze Frischen

Sharon Terry is President and CEO of Genetic Alliance, a leader in transforming health systems by being responsive to the real needs of people in their quest for health. Here, we talk about keeping people in charge of their health data, partnering with scientists to accelerate medical research, and what affordable whole genome sequencing can mean for children and families worldwide.

Konstanze Frischen: Sharon, it’s an exciting time for your work: Genetic Alliance recently received a $120 million in-kind donation of instruments and reagents from Illumina, cloud storage from AWS, and a data management platform from LunaPBC, to bring clinical whole genome sequencing to under-resourced families across the world. Tell us why that matters.

Sharon Terry: 250 million people in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Interview / Q&A, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Trends
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article